Associations - B2M-H - LARVOL VERI

BIOMARKER:

B2M-H

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	ibrutinib Resistant: C3 – Early Trials ibrutinib Resistant : C3
B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	venetoclax + ibrutinib Sensitive: C3 – Early Trials venetoclax + ibrutinib Sensitive : C3
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Immunomodulator Resistant: C3 – Early Trials Immunomodulator Resistant : C3
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Proteasome inhibitor + Immunomodulator Resistant: C3 – Early Trials Proteasome inhibitor + Immunomodulator Resistant : C3
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Proteasome inhibitor Resistant: C3 – Early Trials Proteasome inhibitor Resistant : C3